Cargando…

From macrophage biology to macrophage-based cellular immunotherapies

Detalles Bibliográficos
Autores principales:	Mass, Elvira, Lachmann, Nico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455330/ https://www.ncbi.nlm.nih.gov/pubmed/33542457 http://dx.doi.org/10.1038/s41434-021-00221-5

Ejemplares similares

Cellular backpacks for macrophage immunotherapy
por: Shields, C. Wyatt, et al.
Publicado: (2020)

Tissue-specific macrophages: how they develop and choreograph tissue biology
por: Mass, Elvira, et al.
Publicado: (2023)

Macrophages regulate the clearance of living cells by calreticulin
por: Krysko, Dmitri V., et al.
Publicado: (2018)

Guardians of the epithelium: macrophages protect against toxic fungal derivatives
por: Mowat, Allan M., et al.
Publicado: (2021)

NDRG2 programs tumor-associated macrophages for tumor support
por: von Karstedt, Silvia
Publicado: (2018)

Comments on Research trends of macrophage polarization: a bibliometric analysis
por: Ho, Yuh-Shan
Publicado: (2019)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Cross-kingdom metabolic manipulation promotes Salmonella replication inside macrophages
por: Pérez-Morales, Deyanira, et al.
Publicado: (2021)

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)

Macrophages’ M1 or M2 by tumor microparticles: lysosome makes decision
por: Tang, Ke, et al.
Publicado: (2022)

CNS-associated macrophages shape the inflammatory response in a mouse model of Parkinson’s disease
por: Frosch, Maximilian, et al.
Publicado: (2023)

The Role of Macrophages in Nonischemic Heart Failure
por: Chen, Bijun, et al.
Publicado: (2018)

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy
por: Cao, Xu, et al.
Publicado: (2022)

New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages
por: Haake, Kathrin, et al.
Publicado: (2019)

Macrophage inducible nitric oxide synthase promotes the initiation of lung squamous cell carcinoma by maintaining circulated inflammation
por: Gray, Zane, et al.
Publicado: (2018)

Exosomal miR-19b-3p communicates tubular epithelial cells and M1 macrophage
por: Wang, Zhi-wei, et al.
Publicado: (2019)

CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
por: Abdin, Shifaa M., et al.
Publicado: (2021)

Towards evidence-based response criteria for cancer immunotherapy
por: Garralda, Elena, et al.
Publicado: (2023)

Beyond “Big Eaters”: The Versatile Role of Alveolar Macrophages in Health and Disease
por: Hetzel, Miriam, et al.
Publicado: (2021)

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Immunotherapies for COVID-19: lessons learned from sepsis
por: Remy, Kenneth E, et al.
Publicado: (2020)

Cardiac Macrophages, Reactive Oxygen Species, and Development of Left Ventricular Dysfunction
por: Wang, Yiming, et al.
Publicado: (2017)

Bioengineering of bacteria for cancer immunotherapy
por: Nguyen, Dinh-Huy, et al.
Publicado: (2023)

AS03 stresses out macrophages: Commentary on ‘Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties’
por: Orr, Mark T., et al.
Publicado: (2018)

Comment on: The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Schymik, Hanna S., et al.
Publicado: (2022)

Ferroptosis: a new approach for immunotherapy
por: Zeng, Chong, et al.
Publicado: (2020)

Reply to the Comment on “The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ”
por: Wang, Xia, et al.
Publicado: (2022)

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023)

Illuminating cellular formaldehyde
por: Umansky, Carla, et al.
Publicado: (2021)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)
por: Scadding, Guy
Publicado: (2021)

Targeting macrophages in cancer immunotherapy
por: Duan, Zhaojun, et al.
Publicado: (2021)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)

Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
por: Bodmer, Walter
Publicado: (2022)

Acquired mechanisms of immune escape in cancer following immunotherapy
por: Bryan Iorgulescu, J., et al.
Publicado: (2018)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Comment on: Kadomoto, S. et al. “Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020, 12, 89
por: Zins, Karin, et al.
Publicado: (2020)

Natural selection at the cellular level: insights from male germ cell differentiation
por: Nguyen, Daniel H., et al.
Publicado: (2021)

Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections
por: Ackermann, Mania, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9cfcq76idohuug6iudem4m1u2r